| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.001 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.002 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.002 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |